<DOC>
	<DOCNO>NCT00945178</DOCNO>
	<brief_summary>The study investigate new formulation study drug absorb , metabolise distribute body , well safety tolerability high dos give single multiple dos single dose presence absence naproxen .</brief_summary>
	<brief_title>Double-blind Placebo-controlled 2-part Study Assessing Safety , Tolerability PK AZD1386 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<criteria>Provision sign , write date informed consent prior study specific procedure Healthy male female ( non childbearing potential ) Body Mass Index ( BMI ) ≥19 ≤28 kg/m2 weight ≥50 ≤100 kg History presence clinically significant disease disorder opinion investigator . Any clinically relevant abnormal finding physical examination , clinical chemistry , haematology , urinalysis , vital sign ECG baseline opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Healthy</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>